Severe Esophagitis and Chemical Pneumonitis as a Consequence of Dilute Benzalkonium Chloride Ingestion: A Case Report
Keywords:Ammonium chloride, Benzalkonium chloride, Esophagitis, Quaternary ammonium compounds, Chemical pneumonitis, Esophageal ulceration
Background: Benzalkonium chloride (BAC) has been used as an active ingredient in a wide variety of compounds such as surface disinfectants, floor cleaners, pharmaceutical products and sanitizers. Solutions containing <10% concentration of BACs typically do not cause serious injury. As the available data regarding acute BAC toxicity is limited, we report a case of dilute benzalkonium chloride ingestion resulting in bilateral chemical pneumonitis and significant gastrointestinal injury requiring mechanical ventilatory support.
The Case: A 42-year-old male presented with chief complaints of nausea, vomiting and excessive amount of blood- mixed oral secretions after accidental ingestion of approximately 100ml of BAC solution (<10%). Later he developed respiratory distress with falling oxygen saturation for which he was intubated and mechanical ventilatory support was administered. Computed tomography (CT) chest was suggestive of bilateral chemical pneumonitis and upper gastrointestinal (GI) endoscopy revealed diffuse esophageal ulcerations. The patient was managed with intravenous fluids, corticosteroids, proton pump inhibitor, empiric antibiotics and total parenteral nutrition.
Conclusion: The present case report emphasizes that dilute BAC compounds can cause severe respiratory and gastrointestinal injuries. Immediate and aggressive medical treatment is crucial for improving patient outcomes and reducing the complication rates.
Price PB. Benzalkonium chloride (zephiran chloride) as a skin disinfectant. Arch Surg.1950;61(1):23–33.
Merchel Piovesan Pereira B, Tagkopoulos I. Benzalkonium chlorides: uses, regulatory status, and microbial resistance.Appl Environ Microbiol. 2019;85(13):e00377-19.
Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004;130:131-41.
Hitosugi M, Maruyama, K, Takatsu A. A case of fatal benzalkonium chloride poisoning. Int J Legal Med. 1998;111(5):265–6.
Van Berkel M, de Wolff FA. Survival after acute benzalkonium chloride poisoning. Hum Toxicol. 1988 Mar;7(2):191-3.
Tiess D, Nagel KH. Contribution to the morphology and analysis of invert soap poisoning: 2 cases of fatal acute poisoning caused by oral consumption of the disinfectant C4. Arch Toxikol. 1967;22(5):333–48.
Seymour Stanton Block. Disinfection, Sterilization and Preservation. 5th ed. Lippincott Williams & Wilkins; 2001.
Basketter DA, Marriott M, Gilmour NJ, White IR. Strong irritants masquerading as skin allergens: the case of benzalkonium chloride. Contact Dermatitis. 2004 Apr;50(4):213-7.
Spiller HA. A case of fatal ingestion of a 10% benzalkonium chloride solution. J Forensic Toxicol Pharmacol. 2014;3(1). DOI:10.4172/2325-9841.1000113.
Külbay H, Çevik ŞE, Vural Z. A case of accidental benzalkonium chloride (10 %) ingestion. Turkish Journal of Family Medicine and Primary Care. 2014;8(4):129-132.
Havanond C, Havanond P. Initial signs and symptoms as prognostic indicators of severe gastrointestinal tract injury due to corrosive ingestion. J Emerg Med. 2007 Nov;33(4):349–53.
Kikendall JW. Caustic ingestion injuries. Gastroenterol Clin North Am. 1991 Dec;20(4):847-57.
Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK. Ingestion of strong corrosive alkalis: spectrum of injury to upper gastrointestinal tract and natural history. Am J Gastroenterol. 1992 Mar;87(3):337-41.
Popa CC, Badiu DC, Andronache LF, Costea RV, Neagu SI, Stoian AP, et al. Differential Diagnosis in Esophageal Cancer. Review on literature. Rev Chim. 2019 Jan;70(1):331-5.
Chiejina M, Samant H. Esophageal Ulcer. In StatPearls. StatPearls Publishing. 2021 Jul.
Schaffer SB, Hebert AF. Caustic ingestion. J La State Med Soc. 2000 Dec;152(12):590-6.
Gumaste VV, Dave PB. Ingestion of corrosive substances by adults. Am J Gastroenterol. 1992 Jan;87(1):1-5.
How to Cite
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to firstname.lastname@example.org
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to email@example.com